FindTrial
Sign In

A prospective, randomized, blind, positive parallel controlled, multicenter clinical trial to evaluate the safety and effectiveness of biological skin-based wound dressing in the treatment of deep second degree burn (scald) wounds

A prospective, randomized, blind, positive parallel controlled, multicenter clinical trial to evaluate the safety and effectiveness of biological skin-based wound dressing in the treatment of deep second degree burn (scald) wounds

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052726
Enrollment
Unknown
Registered
2021-11-04
Start date
2017-10-31
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep second degree burn (scald)

Interventions

experimental group:Biological skin based wound dressing
control group:Xenogeneic acellular dermal matrix dressing

Sponsors

Wuhan Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 ~ 65 years (including 18 and 65 years), regardless of gender; 2. The target wound was clinically diagnosed as deep second-degree burn (scald).

Exclusion criteria

Exclusion criteria: 1. Those who are participating in other clinical trials or have not completed the trials within 1 month before enrollment; 2. Other circumstances that the researcher considers inappropriate to participate in the clinical trial.

Design outcomes

Primary

MeasureTime frame
Wound healing rate;—

Countries

China

Contacts

Public ContactXie Weiguo

Wuhan Third Hospital

wgxie@hotmail.com+86 18071085225

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026